Akcea and Ionis Receive Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen)

    NEXT STORY
    Paratek Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference
    PREV STORY
    Mithra Reports 2018 Annual Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Coherus BioSciences Management to Present at 36th NASDAQ OMX Investor Program 

    REDWOOD CITY, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

    author_avatar
    NASDAQ Market News

    Tesaro Announces Presentation of Niraparib Phase 3 ENGOT-OV16/NOVA Trial Secondary Endpoint Results During SGO

    NATIONAL HARBOR, Md., March 13, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused ...

    author_avatar
    NASDAQ Market News

    Turning Point Therapeutics Names Homa Yeganegi Senior Vice President, Project Team Leader and Head of Medical Affairs

    author_avatar
    NASDAQ Market News